Kreyenbuhl JA - Search Results

1

The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

Kreyenbuhl JA, Medoff DR, McEvoy JP, Smith TE, Hackman AL, Nossel IR, Dixon LB, Essock SM, Buchanan RW. Kreyenbuhl JA, et al. Psychiatr Serv. 2016 Dec 1;67(12):1300-1306. doi: 10.1176/appi.ps.201500438. Epub 2016 Jul 1. Psychiatr Serv. 2016. PMID: 27364816 Free PMC article.

2

Relationship of the use of adjunctive pharmacological agents to symptoms and level of function in schizophrenia.

Buchanan RW, Kreyenbuhl J, Zito JM, Lehman A. Buchanan RW, et al. Am J Psychiatry. 2002 Jun;159(6):1035-43. doi: 10.1176/appi.ajp.159.6.1035. Am J Psychiatry. 2002. PMID: 12042194

3

The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome.

Buchanan RW, Kreyenbuhl J, Zito JM, Lehman A. Buchanan RW, et al. Schizophr Bull. 2002;28(1):63-73. doi: 10.1093/oxfordjournals.schbul.a006927. Schizophr Bull. 2002. PMID: 12047023

4

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

Koro CE, Fedder DO, L'Italien GJ, Weiss SS, Magder LS, Kreyenbuhl J, Revicki DA, Buchanan RW. Koro CE, et al. BMJ. 2002 Aug 3;325(7358):243. doi: 10.1136/bmj.325.7358.243. BMJ. 2002. PMID: 12153919 Free PMC article.

5

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.

Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, Revicki D, Buchanan RW. Koro CE, et al. Arch Gen Psychiatry. 2002 Nov;59(11):1021-6. doi: 10.1001/archpsyc.59.11.1021. Arch Gen Psychiatry. 2002. PMID: 12418935

6

Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services.

Dickerson FB, McNary SW, Brown CH, Kreyenbuhl J, Goldberg RW, Dixon LB. Dickerson FB, et al. Med Care. 2003 Apr;41(4):560-70. doi: 10.1097/01.MLR.0000053440.18761.F0. Med Care. 2003. PMID: 12665719

7

Racial disparity in the pharmacological management of schizophrenia.

Kreyenbuhl J, Zito JM, Buchanan RW, Soeken KL, Lehman AF. Kreyenbuhl J, et al. Schizophr Bull. 2003;29(2):183-93. doi: 10.1093/oxfordjournals.schbul.a006996. Schizophr Bull. 2003. PMID: 14552495

8

Evidence-based treatment for schizophrenia.

Lehman AF, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden L, Kreyenbuhl J. Lehman AF, et al. Psychiatr Clin North Am. 2003 Dec;26(4):939-54. doi: 10.1016/s0193-953x(03)00070-4. Psychiatr Clin North Am. 2003. PMID: 14711129 Review.

9

Practice guideline for the treatment of patients with schizophrenia, second edition.

Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Practice Guidelines. Lehman AF, et al. Among authors: kreyenbuhl j. Am J Psychiatry. 2004 Feb;161(2 Suppl):1-56. Am J Psychiatry. 2004. PMID: 15000267 Review. No abstract available.

10

Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services.

Sokal J, Messias E, Dickerson FB, Kreyenbuhl J, Brown CH, Goldberg RW, Dixon LB. Sokal J, et al. J Nerv Ment Dis. 2004 Jun;192(6):421-7. doi: 10.1097/01.nmd.0000130135.78017.96. J Nerv Ment Dis. 2004. PMID: 15167405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters